Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Clinical trial NCT04119024 · RECRUITING

Trial details

NCT number: NCT04119024
Sponsor: Anusha Kalbasi
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Malignant Solid Neoplasm Metastatic Melanoma Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Pathologic Stage IV Cutaneous Melanoma AJCC v8 Recurrent Malignant Solid Neoplasm Refractory Malignant Solid Neoplasm Uveal Melanoma Acral Melanoma Neuroendocrine Tumors Paraganglioma Pheochromocytoma Adrenocortical Carcinoma

Start date: 2025-10-07
Primary completion: 2026-10-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.